During the 3-Year Crimean war, 53% of deaths amongst the troops resulted from diseases while 27% died in action and the remaining 20% lost their lives due to their wounds. Thus, efficient healthcare systems became the primary target of all nations, given their irrefutable role in improving people’s health throughout their lifespan.
Substantial spending on healthcare and pharmaceutical drugs characterizes advanced economies. For instance, the United States nearly associated 17.1% in total (public and private contributions) of their Gross Domestic Product (GDP) in 2012 for health purposes while the share almost reached 11.5% of GDP in each of France and Switzerland. In fact, the average health expenditure in the Organization for Economic Cooperation and Development (OECD) countries stood at 9.3% of GDP over the same period.
To read the full report, click on the link below:
The Saga of the Lebanese Healthcare Sector Reforms on the Run amid Persistent Challenges